EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - OncoTargets and …, 2017 - Taylor & Francis
Background EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …
被引用次数：64 相关文章

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - OncoTargets & …, 2017 - search.ebscohost.com
Background: EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …

EGFRmutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - OncoTargets and …, 2017 - search.proquest.com
Background: EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFRmutation-positive adenocarcinomas of the lung. In contrast, the significance of …
[PDF] scienceopen.com

[PDF][PDF] EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

VM Patil, K Prabhash - OncoTargets and Therapy, 2017 - scienceopen.com
Background: EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - Oncotargets and …, 2017 - europepmc.org
Background EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …
[HTML] nih.gov

[HTML][HTML] EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - OncoTargets and …, 2017 - ncbi.nlm.nih.gov
Background EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha… - OncoTargets and …, 2017 - pubmed.ncbi.nlm.nih.gov
Background EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - OncoTargets and …, 2017 - go.gale.com
Background: EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …
[PDF] academia.edu

[PDF][PDF] EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

VM Patil, K Prabhash - OncoTargets and Therapy, 2017 - academia.edu
Background: EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of
EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR …

[引用][C] EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

A Joshi, S Zanwar, V Noronha, VM Patil… - OncoTargets and …, 2017 - cir.nii.ac.jp
<em>EGFR </em>mutation in squamous cell carcinoma of the lung: does it carry the same
connotation as in adenocarcinomas? | CiNii Research CiNii 国立情報学研究所 学術情報 …